PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35506380-10	2022	AS-/- mice exhibited transient Na+ wasting under low-salt diet, but administration of the MR antagonist eplerenone to AS-/- mice led to hyperkalemia and decreased body weight with higher Na+ excretion, mimicking the phenotype of MR-/- mice.	Eplerenone	104-114	cytochrome P450, family 11, subfamily b, polypeptide 2	Mus musculus	0-2	
35506380-10	2022	AS-/- mice exhibited transient Na+ wasting under low-salt diet, but administration of the MR antagonist eplerenone to AS-/- mice led to hyperkalemia and decreased body weight with higher Na+ excretion, mimicking the phenotype of MR-/- mice.	Eplerenone	104-114	cytochrome P450, family 11, subfamily b, polypeptide 2	Mus musculus	118-120	
23232789-7	2012	Messenger RNA expression of the mineralocorticoid receptor and aldosterone synthase were also reduced by eplerenone to a greater extent in early ATS, and these might increase the sensitivity of macrophages to mineralocorticoid blockade in early ATS.	Eplerenone	105-115	cytochrome P450, family 11, subfamily b, polypeptide 2	Mus musculus	63-83	
19255254-7	2009	Eplerenone (an aldosterone antagonist) abolished all of the effects of aldosterone-synthase overexpression but had no effect in Wt-D mice.	Eplerenone	0-10	cytochrome P450, family 11, subfamily b, polypeptide 2	Mus musculus	71-91